miRNA-495 通过靶向 FAM83D 抑制结直肠癌细胞的增殖和迁移。
miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
机构信息
Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
出版信息
Biomed Pharmacother. 2017 Dec;96:974-981. doi: 10.1016/j.biopha.2017.11.138. Epub 2017 Dec 6.
microRNAs (miRNAs) have been reported to play crucial roles in malignant tumor progression, including cell development, proliferation, and progression. Increasing evidence suggests that miR-495 functions as either an oncogene or tumor suppressor in several tumor types. However, its biological role in the development of colorectal cancer (CRC) still remains unclear. In this study, we found that miR-495 expression level was remarkably down-regulated in CRC tissues samples and cell lines when compared to adjacent normal tissues and cell line by using qRT-PCR detection. Ectopic expression of miR-495 by mimic transfection significantly suppressed CRC cell proliferation and colony formation, inhibited migration and invasion, and induced apoptosis according to CCK-8, colony formation, transwell, and flow cytometry assays. Furthermore, bioinformatics and luciferase reporter assays verified that family with sequence similarity 83, member D (FAM83D) was a direct target of miR-495 in CRC cells, and FAM83D was confirmed to be upregulated in human CRC tissues and reversely correlated with miR-495 expression. In addition, rescue experiments revealed that restoration of FAM84D could partially abrogate the inhibitory effect of miR-495 overexpression on CRC cell proliferation and metastasis. Further mechanic investigations also verified that the PTEN/P13K/AKT/mTOR pathway was involved in the miR-495/FAM83D-mediated CRC cell progression. Our findings identified that miR-495 acted as a critical tumor suppressor by directly targeting FAM83D during CRC development and therefore represented as a potential biomarker for CRC therapy.
microRNAs (miRNAs) 在恶性肿瘤的进展中发挥着至关重要的作用,包括细胞的发育、增殖和进展。越来越多的证据表明,miR-495 在几种肿瘤类型中既可以作为癌基因,也可以作为肿瘤抑制因子发挥作用。然而,其在结直肠癌(CRC)发展中的生物学作用仍不清楚。在本研究中,我们通过 qRT-PCR 检测发现,与相邻正常组织和细胞系相比,CRC 组织样本和细胞系中的 miR-495 表达水平显著下调。通过 mimic 转染过表达 miR-495 可显著抑制 CRC 细胞的增殖和集落形成,抑制迁移和侵袭,并通过 CCK-8、集落形成、transwell 和流式细胞术实验诱导细胞凋亡。此外,生物信息学和荧光素酶报告基因实验验证了 FAM83D 是 CRC 细胞中 miR-495 的直接靶基因,并且 FAM83D 在人 CRC 组织中上调,并与 miR-495 的表达呈负相关。此外,挽救实验表明,FAM83D 的恢复可以部分抵消 miR-495 过表达对 CRC 细胞增殖和转移的抑制作用。进一步的机制研究还验证了 miR-495/FAM83D 介导的 CRC 细胞进展涉及 PTEN/P13K/AKT/mTOR 通路。我们的研究结果表明,miR-495 通过直接靶向 FAM83D 在 CRC 发展中发挥关键的肿瘤抑制作用,因此可作为 CRC 治疗的潜在生物标志物。